| pubmed-article:1826823 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C0014173 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:1826823 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
| pubmed-article:1826823 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1826823 | pubmed:dateCreated | 1991-5-23 | lld:pubmed |
| pubmed-article:1826823 | pubmed:abstractText | Endometrial hyperplasia has since long been proposed to be a predecessor to endometrial carcinoma. In this prospective randomised study one group was treated with abrasio only at regular intervals to follow the natural course. In this group 96/176 were normalised after a 2 year follow-up and 3 patients developed cancer. The frequency of normalised patients after abrasio only (55%) resembles that of cyclic low-dose gestagen treatment. In the other patient group treated with Medroxy progesterone acetate 500 mg i.m. twice weekly for 3 months and then followed for 2 years, 86/89 normalised and none developed cancer. | lld:pubmed |
| pubmed-article:1826823 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1826823 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1826823 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1826823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1826823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1826823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1826823 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1826823 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:1826823 | pubmed:author | pubmed-author:WillénRR | lld:pubmed |
| pubmed-article:1826823 | pubmed:author | pubmed-author:LindahlBB | lld:pubmed |
| pubmed-article:1826823 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1826823 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:1826823 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1826823 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1826823 | pubmed:pagination | 403-6 | lld:pubmed |
| pubmed-article:1826823 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:meshHeading | pubmed-meshheading:1826823-... | lld:pubmed |
| pubmed-article:1826823 | pubmed:articleTitle | Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients. | lld:pubmed |
| pubmed-article:1826823 | pubmed:affiliation | Department of Obstetrics and Gynecology, Lund University Hospital, Sweden. | lld:pubmed |
| pubmed-article:1826823 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1826823 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1826823 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1826823 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:1826823 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1826823 | lld:pubmed |
